MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,849,201 | -0.2% | 166,057 | 0.0% | 0.07% | +16.9% |
Q1 2023 | $3,857,504 | -2.4% | 166,057 | -39.0% | 0.06% | +22.9% |
Q4 2022 | $3,951,900 | -78.8% | 272,357 | -72.1% | 0.05% | -78.5% |
Q3 2022 | $18,606,000 | -13.2% | 975,157 | -17.4% | 0.22% | -10.8% |
Q2 2022 | $21,442,000 | +627.1% | 1,180,057 | +908.3% | 0.25% | +681.2% |
Q1 2022 | $2,949,000 | -84.5% | 117,037 | -80.2% | 0.03% | -83.0% |
Q3 2021 | $19,083,000 | +132.0% | 591,000 | +68.9% | 0.19% | -46.1% |
Q3 2013 | $8,225,000 | – | 350,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |